Published in Lancet Oncol on February 22, 2012
Aspirin, nonaspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: a pooled analysis in the Ovarian Cancer Association Consortium. J Natl Cancer Inst (2014) 2.40
Plasma microRNAs as novel biomarkers for endometriosis and endometriosis-associated ovarian cancer. Clin Cancer Res (2013) 2.15
Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer. Nat Commun (2013) 1.73
In vitro fertilization and risk of breast and gynecologic cancers: a retrospective cohort study within the Israeli Maccabi Healthcare Services. Fertil Steril (2013) 1.59
Infertility etiologies are genetically and clinically linked with other diseases in single meta-diseases. Reprod Biol Endocrinol (2015) 1.51
Identification of six new susceptibility loci for invasive epithelial ovarian cancer. Nat Genet (2015) 1.47
Endometriosis and Risk of Coronary Heart Disease. Circ Cardiovasc Qual Outcomes (2016) 1.40
Loss of ARID1A expression is an early molecular event in tumor progression from ovarian endometriotic cyst to clear cell and endometrioid carcinoma. Int J Gynecol Cancer (2012) 1.26
Biomarker-based ovarian carcinoma typing: a histologic investigation in the ovarian tumor tissue analysis consortium. Cancer Epidemiol Biomarkers Prev (2013) 1.22
Hormone response in ovarian cancer: time to reconsider as a clinical target? Endocr Relat Cancer (2012) 1.20
ARID1A mutations and PI3K/AKT pathway alterations in endometriosis and endometriosis-associated ovarian carcinomas. Int J Mol Sci (2013) 1.14
Tubal ligation and risk of ovarian cancer subtypes: a pooled analysis of case-control studies. Int J Epidemiol (2013) 1.10
Angiogenesis and its therapeutic opportunities. Mediators Inflamm (2013) 1.09
Risk and prognosis of ovarian cancer in women with endometriosis: a meta-analysis. Br J Cancer (2014) 1.09
Defining future directions for endometriosis research: workshop report from the 2011 World Congress of Endometriosis In Montpellier, France. Reprod Sci (2013) 1.06
Reproductive characteristics in relation to ovarian cancer risk by histologic pathways. Hum Reprod (2013) 1.06
Combined and interactive effects of environmental and GWAS-identified risk factors in ovarian cancer. Cancer Epidemiol Biomarkers Prev (2013) 1.02
Endometriosis-associated ovarian cancer: a review of pathogenesis. Int J Mol Sci (2013) 1.01
Bisphenol A and phthalates and endometriosis: the Endometriosis: Natural History, Diagnosis and Outcomes Study. Fertil Steril (2013) 1.01
Oxidative stress and the ageing endocrine system. Nat Rev Endocrinol (2013) 1.00
Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA. Hum Genet (2013) 0.99
Pathogenesis and the role of ARID1A mutation in endometriosis-related ovarian neoplasms. Adv Anat Pathol (2013) 0.99
Targeting signaling pathways in epithelial ovarian cancer. Int J Mol Sci (2013) 0.98
World Endometriosis Research Foundation Endometriosis Phenome and Biobanking Harmonization Project: II. Clinical and covariate phenotype data collection in endometriosis research. Fertil Steril (2014) 0.98
Endometriosis: a high-risk population for major chronic diseases? Hum Reprod Update (2015) 0.97
Epigenome-wide ovarian cancer analysis identifies a methylation profile differentiating clear-cell histology with epigenetic silencing of the HERG K+ channel. Hum Mol Genet (2013) 0.97
Endometriosis, a disease of the macrophage. Front Immunol (2013) 0.97
Ovarian Cancer Risk Factors by Histologic Subtype: An Analysis From the Ovarian Cancer Cohort Consortium. J Clin Oncol (2016) 0.96
Iron and thiols as two major players in carcinogenesis: friends or foes? Front Pharmacol (2014) 0.91
Non-steroidal anti-inflammatory drug use and ovarian cancer risk: findings from the NIH-AARP Diet and Health Study and systematic review. Cancer Causes Control (2012) 0.91
Molecular signatures of epithelial ovarian cancer: analysis of associations with tumor characteristics and epidemiologic risk factors. Cancer Epidemiol Biomarkers Prev (2013) 0.91
Update on Biomarkers for the Detection of Endometriosis. Biomed Res Int (2015) 0.90
Risk of ovarian cancer and the NF-κB pathway: genetic association with IL1A and TNFSF10. Cancer Res (2013) 0.89
Complement pathway is frequently altered in endometriosis and endometriosis-associated ovarian cancer. Clin Cancer Res (2014) 0.89
Use of fertility drugs and risk of ovarian cancer: results from a U.S.-based case-control study. Cancer Epidemiol Biomarkers Prev (2012) 0.89
Early pregnancy sex steroids and maternal risk of epithelial ovarian cancer. Endocr Relat Cancer (2014) 0.88
Metastatic adenocarcinoma after laparoscopic supracervical hysterectomy with morcellation: A case report. Gynecol Oncol Case Rep (2013) 0.88
Cell-type-specific enrichment of risk-associated regulatory elements at ovarian cancer susceptibility loci. Hum Mol Genet (2015) 0.88
The OncoArray Consortium: a Network for Understanding the Genetic Architecture of Common Cancers. Cancer Epidemiol Biomarkers Prev (2016) 0.87
Interdisciplinary S2k Guidelines for the Diagnosis and Treatment of Endometriosis: Short Version - AWMF Registry No. 015-045, August 2013. Geburtshilfe Frauenheilkd (2013) 0.87
The immune system in the pathogenesis of ovarian cancer. Crit Rev Immunol (2013) 0.86
Ovarian cancer risk factors by tumor dominance, a surrogate for cell of origin. Int J Cancer (2013) 0.86
Robust gene expression and mutation analyses of RNA-sequencing of formalin-fixed diagnostic tumor samples. Sci Rep (2015) 0.86
An Update on Surgical versus Expectant Management of Ovarian Endometriomas in Infertile Women. Biomed Res Int (2015) 0.86
Nightshift work and risk of ovarian cancer. Occup Environ Med (2013) 0.85
The use of HE4, CA125 and CA72-4 biomarkers for differential diagnosis between ovarian endometrioma and epithelial ovarian cancer. J Ovarian Res (2013) 0.85
An epidemiologic risk prediction model for ovarian cancer in Europe: the EPIC study. Br J Cancer (2015) 0.85
Association between Body Powder Use and Ovarian Cancer: The African American Cancer Epidemiology Study (AACES). Cancer Epidemiol Biomarkers Prev (2016) 0.84
Retracted Targeted immune therapy of ovarian cancer. Cancer Metastasis Rev (2015) 0.84
Tubal ligation, hysterectomy and epithelial ovarian cancer in the New England Case-Control Study. Int J Cancer (2013) 0.84
Opportunistic salpingectomy for ovarian cancer prevention. Gynecol Oncol Res Pract (2015) 0.84
Genome-wide significant risk associations for mucinous ovarian carcinoma. Nat Genet (2015) 0.83
An increased risk of epithelial ovarian cancer in Taiwanese women with a new surgico-pathological diagnosis of endometriosis. BMC Cancer (2014) 0.82
Endometriosis and ovarian cancer risk: a systematic review of epidemiological studies. Front Surg (2014) 0.82
MiR-191 inhibits TNF-α induced apoptosis of ovarian endometriosis and endometrioid carcinoma cells by targeting DAPK1. Int J Clin Exp Pathol (2015) 0.82
Dietary carbohydrate intake, glycaemic load, glycaemic index and ovarian cancer risk in African-American women. Br J Nutr (2015) 0.82
PTEN expression in benign human endometrial tissue and cancer in relation to endometrial cancer risk factors. Cancer Causes Control (2015) 0.81
Differentially methylated loci distinguish ovarian carcinoma histological types: evaluation of a DNA methylation assay in FFPE tissue. Biomed Res Int (2013) 0.81
Shared genetics underlying epidemiological association between endometriosis and ovarian cancer. Hum Mol Genet (2015) 0.81
[Endometriosis-related ovarian tumors]. Pathologe (2014) 0.81
Dairy food and nutrient intake in different life periods in relation to risk of ovarian cancer. Cancer Causes Control (2014) 0.81
Allelic Imbalance in Regulation of ANRIL through Chromatin Interaction at 9p21 Endometriosis Risk Locus. PLoS Genet (2016) 0.81
The disparate origins of ovarian cancers: pathogenesis and prevention strategies. Nat Rev Cancer (2016) 0.81
MRI for differentiating ovarian endometrioid adenocarcinoma from high-grade serous adenocarcinoma. J Ovarian Res (2015) 0.80
Puerperal mastitis: a reproductive event of importance affecting anti-mucin antibody levels and ovarian cancer risk. Cancer Causes Control (2013) 0.80
DNA methylation changes in epithelial ovarian cancer histotypes. Genomics (2015) 0.80
Novel three-dimensional in vitro models of ovarian endometriosis. J Ovarian Res (2014) 0.80
Recent alcohol consumption and risk of incident ovarian carcinoma: a pooled analysis of 5,342 cases and 10,358 controls from the Ovarian Cancer Association Consortium. BMC Cancer (2013) 0.80
Pathogenesis of serous, extra-uterine Müllerian epithelial cancer and therapeutic implications. Transl Cancer Res (2015) 0.80
Is CA72-4 a useful biomarker in differential diagnosis between ovarian endometrioma and epithelial ovarian cancer? Dis Markers (2013) 0.80
Association Between Menopausal Estrogen-Only Therapy and Ovarian Carcinoma Risk. Obstet Gynecol (2016) 0.80
Cytotoxic T-Cells in Peripheral Blood in Women with Endometriosis. Geburtshilfe Frauenheilkd (2013) 0.79
Somatic copy number alterations associated with Japanese or endometriosis in ovarian clear cell adenocarcinoma. PLoS One (2015) 0.79
Incidence of epithelial ovarian cancer according to histologic subtypes in Korea, 1999 to 2012. J Gynecol Oncol (2015) 0.79
Link between endometriosis and ovarian-cancer subtypes. Lancet Oncol (2012) 0.79
Chronic Recreational Physical Inactivity and Epithelial Ovarian Cancer Risk: Evidence from the Ovarian Cancer Association Consortium. Cancer Epidemiol Biomarkers Prev (2016) 0.78
National German Guideline (S2k): Guideline for the Diagnosis and Treatment of Endometriosis: Long Version - AWMF Registry No. 015-045. Geburtshilfe Frauenheilkd (2014) 0.78
MUC1 positive, Kras and Pten driven mouse gynecologic tumors replicate human tumors and vary in survival and nuclear grade based on anatomical location. PLoS One (2014) 0.78
Phenotypic heterogeneity of hereditary gynecologic cancers: a report from the Creighton hereditary cancer registry. Fam Cancer (2013) 0.78
Models of endometriosis and their utility in studying progression to ovarian clear cell carcinoma. J Pathol (2016) 0.78
Dietary fat intake and risk of epithelial ovarian cancer by tumour histology. Br J Cancer (2014) 0.78
The Risk of Epithelial Ovarian Cancer of Women With Endometriosis May be Varied Greatly if Diagnostic Criteria Are Different: A Nationwide Population-Based Cohort Study. Medicine (Baltimore) (2015) 0.78
Pathogenesis of Endometriosis: Roles of Retinoids and Inflammatory Pathways. Semin Reprod Med (2015) 0.78
Improved clinical outcomes of patients with ovarian carcinoma arising in endometriosis. Oncotarget (2016) 0.77
The prognostic value of pretreatment CA-125 levels and CA-125 normalization in ovarian clear cell carcinoma: a two-academic-institute study. Oncotarget (2016) 0.77
Endometriosis-associated Malignancy. Geburtshilfe Frauenheilkd (2016) 0.77
TNF-α expression, risk factors, and inflammatory exposures in ovarian cancer: evidence for an inflammatory pathway of ovarian carcinogenesis? Hum Pathol (2016) 0.77
Oncolytic virotherapy for ovarian cancer. Oncolytic Virother (2012) 0.77
Reproductive and hormonal factors in relation to survival and platinum resistance among ovarian cancer cases. Br J Cancer (2016) 0.77
Consortium analysis of gene and gene-folate interactions in purine and pyrimidine metabolism pathways with ovarian carcinoma risk. Mol Nutr Food Res (2014) 0.77
Retracted Risk factors for ovarian cancers with and without microsatellite instability. Int J Gynecol Cancer (2013) 0.77
MiR-191 modulates malignant transformation of endometriosis through regulating TIMP3. Med Sci Monit (2015) 0.77
Endometriosis and infertility: how and when to treat? Front Surg (2014) 0.77
Endometriosis and ovarian cancer. Lancet Oncol (2012) 0.77
Down-regulation of ARID1A is sufficient to initiate neoplastic transformation along with epigenetic reprogramming in non-tumorigenic endometriotic cells. Cancer Lett (2017) 0.76
Inhibition of adhesion, proliferation, and invasion of primary endometriosis and endometrial stromal and ovarian carcinoma cells by a nonhyaluronan adhesion barrier gel. Biomed Res Int (2015) 0.76
Endometriosis: where are we and where are we going? Reproduction (2016) 0.76
Evidence of a genetic link between endometriosis and ovarian cancer. Fertil Steril (2015) 0.76
Chronic inflammation in endometriosis and endometriosis-associated ovarian cancer: New roles for the "old" complement pathway. Oncoimmunology (2015) 0.75
ARID1A mutations in endometriosis-associated ovarian carcinomas. N Engl J Med (2010) 13.07
The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory. Am J Surg Pathol (2010) 7.27
Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer--shifting the paradigm. Hum Pathol (2011) 5.53
Ovarian tumors in a cohort of infertile women. N Engl J Med (1994) 4.91
Epidemiology of endometriosis. Obstet Gynecol Clin North Am (1997) 4.79
Much ado about nothing: a comparison of the performance of meta-analytical methods with rare events. Stat Med (2007) 4.56
Cancer risk after a hospital discharge diagnosis of endometriosis. Am J Obstet Gynecol (1997) 3.10
Risk of cancer after use of fertility drugs with in-vitro fertilisation. Lancet (1999) 2.39
Endometriosis and ovarian cancer: thoughts on shared pathophysiology. Am J Obstet Gynecol (2003) 2.25
Talcum powder, chronic pelvic inflammation and NSAIDs in relation to risk of epithelial ovarian cancer. Int J Cancer (2008) 2.14
Tumor cell type can be reproducibly diagnosed and is of independent prognostic significance in patients with maximally debulked ovarian carcinoma. Hum Pathol (2008) 2.09
Infertility, fertility drugs, and ovarian cancer: a pooled analysis of case-control studies. Am J Epidemiol (2002) 2.02
Tagging single nucleotide polymorphisms in cell cycle control genes and susceptibility to invasive epithelial ovarian cancer. Cancer Res (2007) 1.92
Hormonal factors and the risk of invasive ovarian cancer: a population-based case-control study. Fertil Steril (2004) 1.81
Differences in risk factors for epithelial ovarian cancer by histologic type. Results of a case-control study. Am J Epidemiol (1996) 1.71
Endometriosis and the risk of cancer with special emphasis on ovarian cancer. Hum Reprod (2006) 1.69
Histologic types of epithelial ovarian cancer: have they different risk factors? Gynecol Oncol (2005) 1.69
Risk of developing ovarian cancer among women with ovarian endometrioma: a cohort study in Shizuoka, Japan. Int J Gynecol Cancer (2007) 1.64
Risk factors for epithelial ovarian cancer by histologic subtype. Am J Epidemiol (2009) 1.62
The search for genes contributing to endometriosis risk. Hum Reprod Update (2008) 1.58
Histologic transformation of benign endometriosis to early epithelial ovarian cancer. Gynecol Oncol (1996) 1.54
Ovarian cancer risk associated with varying causes of infertility. Fertil Steril (2004) 1.52
Markers of inflammation and risk of ovarian cancer in Los Angeles County. Int J Cancer (2009) 1.52
Low-dose oral contraceptives: protective effect on ovarian cancer risk. Int J Cancer (2001) 1.47
Hormonal risk factors for ovarian cancer in premenopausal and postmenopausal women. Am J Epidemiol (2008) 1.46
Androgen receptor cytosine, adenine, guanine repeats, and haplotypes in relation to ovarian cancer risk. Cancer Res (2005) 1.45
Cancer risk estimates for family members of a population-based family registry for breast and ovarian cancer. Cancer Epidemiol Biomarkers Prev (2000) 1.44
Molecular abnormalities in ovarian cancer subtypes other than high-grade serous carcinoma. J Oncol (2009) 1.43
Cancer risk after hospital discharge diagnosis of benign ovarian cysts and endometriosis. Acta Obstet Gynecol Scand (2004) 1.38
Progesterone receptor variation and risk of ovarian cancer is limited to the invasive endometrioid subtype: results from the Ovarian Cancer Association Consortium pooled analysis. Br J Cancer (2008) 1.38
Hormone therapy and the impact of estrogen intake on the risk of ovarian cancer. Arch Intern Med (2004) 1.37
PGR +331 A/G and increased risk of epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev (2006) 1.37
Postmenopausal cancer risk after self-reported endometriosis diagnosis in the Iowa Women's Health Study. Cancer (2002) 1.35
Contraception methods, beyond oral contraceptives and tubal ligation, and risk of ovarian cancer. Ann Epidemiol (2010) 1.33
Relationship of benign gynecologic diseases to subsequent risk of ovarian and uterine tumors. Cancer Epidemiol Biomarkers Prev (2005) 1.32
Reproductive risk factors for epithelial ovarian cancer according to histologic type and invasiveness. Ann Epidemiol (2001) 1.31
Ovarian cancer risk and common variation in the sex hormone-binding globulin gene: a population-based case-control study. BMC Cancer (2007) 1.27
Cell cycle genes and ovarian cancer susceptibility: a tagSNP analysis. Br J Cancer (2009) 1.19
Recruitment of newly diagnosed ovarian cancer patients proved challenging in a multicentre biobanking study. J Clin Epidemiol (2010) 1.18
Bias versus causality: interpreting recent evidence of association between endometriosis and ovarian cancer. Fertil Steril (2007) 1.09
Risk of epithelial ovarian cancer in relation to benign ovarian conditions and ovarian surgery. Cancer Causes Control (2008) 1.08
Pooled analysis of the association of PTGS2 rs5275 polymorphism and NSAID use with invasive ovarian carcinoma risk. Cancer Causes Control (2010) 1.07
Ovarian clear cell carcinoma with papillary features: a potential mimic of serous tumor of low malignant potential. Am J Surg Pathol (2008) 0.92
Genome-wide association study identifies novel breast cancer susceptibility loci. Nature (2007) 29.23
Oncogenic pathway signatures in human cancers as a guide to targeted therapies. Nature (2005) 19.56
X-ray structure of a voltage-dependent K+ channel. Nature (2003) 14.50
Multiple regions within 8q24 independently affect risk for prostate cancer. Nat Genet (2007) 14.37
Body-mass index and mortality among 1.46 million white adults. N Engl J Med (2010) 13.34
ARID1A mutations in endometriosis-associated ovarian carcinomas. N Engl J Med (2010) 13.07
Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol (2011) 12.10
Crystal structure and mechanism of a calcium-gated potassium channel. Nature (2002) 10.03
Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations. Nat Genet (2002) 9.71
The open pore conformation of potassium channels. Nature (2002) 9.09
Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes. J Clin Oncol (2012) 8.74
Large-scale genotyping identifies 41 new loci associated with breast cancer risk. Nat Genet (2013) 8.24
A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women. N Engl J Med (2015) 7.99
Ethnic and racial differences in the smoking-related risk of lung cancer. N Engl J Med (2006) 7.82
Retracted Genomic signatures to guide the use of chemotherapeutics. Nat Med (2006) 7.45
A common coding variant in CASP8 is associated with breast cancer risk. Nat Genet (2007) 7.35
Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2. Nat Genet (2009) 7.30
A common genetic risk factor for colorectal and prostate cancer. Nat Genet (2007) 7.11
Meta-analysis of genome-wide association data identifies four new susceptibility loci for colorectal cancer. Nat Genet (2008) 6.97
The principle of gating charge movement in a voltage-dependent K+ channel. Nature (2003) 6.94
Genome-wide association scan identifies a colorectal cancer susceptibility locus on 11q23 and replicates risk loci at 8q24 and 18q21. Nat Genet (2008) 6.75
Protection from colorectal cancer after colonoscopy: a population-based, case-control study. Ann Intern Med (2011) 6.50
Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment. JAMA (2006) 6.48
Dietary fat reduction and breast cancer outcome: interim efficacy results from the Women's Intervention Nutrition Study. J Natl Cancer Inst (2006) 6.41
Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics. PLoS Genet (2008) 6.22
Age-dependent DNA methylation of genes that are suppressed in stem cells is a hallmark of cancer. Genome Res (2010) 6.03
Dental x-rays and risk of meningioma. Cancer (2012) 5.99
Multiple loci with different cancer specificities within the 8q24 gene desert. J Natl Cancer Inst (2008) 5.82
Choosing haplotype-tagging SNPS based on unphased genotype data using a preliminary sample of unrelated subjects with an example from the Multiethnic Cohort Study. Hum Hered (2003) 5.78
Retracted An integrated genomic-based approach to individualized treatment of patients with advanced-stage ovarian cancer. J Clin Oncol (2007) 5.77
Prediction of BRCA1 status in patients with breast cancer using estrogen receptor and basal phenotype. Clin Cancer Res (2005) 5.70
Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancer. Cancer Res (2004) 5.68
Mutation of FOXL2 in granulosa-cell tumors of the ovary. N Engl J Med (2009) 5.63
A genome-wide association study of lung cancer identifies a region of chromosome 5p15 associated with risk for adenocarcinoma. Am J Hum Genet (2009) 5.62
Rethinking ovarian cancer: recommendations for improving outcomes. Nat Rev Cancer (2011) 5.28
Age-related lobular involution and risk of breast cancer. J Natl Cancer Inst (2006) 5.12
The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in generally HPV-naive women aged 16-26 years. J Infect Dis (2009) 5.09
Association between CYP2D6 polymorphisms and outcomes among women with early stage breast cancer treated with tamoxifen. JAMA (2009) 5.05
Spectrum of cancer risk among US solid organ transplant recipients. JAMA (2011) 4.99
A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population. Nat Genet (2010) 4.96
Impact of socioeconomic status on cancer incidence and stage at diagnosis: selected findings from the surveillance, epidemiology, and end results: National Longitudinal Mortality Study. Cancer Causes Control (2008) 4.56
Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies. J Natl Cancer Inst (2010) 4.54
The Breast Cancer Family Registry: an infrastructure for cooperative multinational, interdisciplinary and translational studies of the genetic epidemiology of breast cancer. Breast Cancer Res (2004) 4.54
Common variants at 19p13 are associated with susceptibility to ovarian cancer. Nat Genet (2010) 4.51
FKBP51 affects cancer cell response to chemotherapy by negatively regulating Akt. Cancer Cell (2009) 4.48
A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2. Nat Genet (2009) 4.38